• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    CytRx Corporation (CYTR)

    -NasdaqCM
    5.13 Down 0.13(2.47%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:5.26
    Open:5.30
    Bid:5.05 x 10000
    Ask:5.38 x 1000
    1y Target Est:9.33
    Beta:1.15
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:5.10 - 5.37
    52wk Range:2.08 - 5.46
    Volume:906,959
    Avg Vol (3m):960,032
    Market Cap:285.86M
    P/E (ttm):N/A
    EPS (ttm):-0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 2.47%285.86M
    LLYDown 1.13%75.92B
    NVSDown 1.16%250.13B
    SNYDown 0.02%135.32B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2,930.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.89
    Quarterly EPS Est (Mar-15) :-0.21
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback